| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.01B | 84.77B | 81.76B | 94.44B | 81.75B | 66.81B |
| Gross Profit | 10.81B | 13.93B | 14.21B | 16.55B | 15.44B | 11.77B |
| EBITDA | 10.11B | 7.57B | 10.81B | 12.73B | 11.69B | 8.54B |
| Net Income | 3.54B | 3.33B | 3.68B | 5.36B | 5.05B | 2.98B |
Balance Sheet | ||||||
| Total Assets | 68.97B | 69.88B | 66.81B | 68.28B | 63.59B | 55.31B |
| Cash, Cash Equivalents and Short-Term Investments | 4.44B | 2.19B | 2.08B | 3.19B | 4.71B | 5.80B |
| Total Debt | 26.36B | 24.21B | 20.83B | 20.22B | 19.02B | 18.35B |
| Total Liabilities | 47.06B | 45.66B | 43.92B | 44.58B | 44.09B | 41.23B |
| Stockholders Equity | 21.61B | 23.79B | 22.48B | 23.24B | 19.04B | 13.78B |
Cash Flow | ||||||
| Free Cash Flow | 6.56B | 5.79B | 5.88B | 7.05B | 6.26B | 4.78B |
| Operating Cash Flow | 9.42B | 8.72B | 9.26B | 10.96B | 9.99B | 7.70B |
| Investing Cash Flow | -3.12B | -2.39B | -2.18B | -3.18B | -4.82B | -3.64B |
| Financing Cash Flow | -5.29B | -6.35B | -6.90B | -7.41B | -6.22B | -2.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $61.66B | 12.82 | 15.56% | 3.81% | 2.62% | 14.95% | |
73 Outperform | $89.94B | 17.37 | 15.87% | 1.94% | 3.09% | 14.94% | |
73 Outperform | $18.18B | 10.88 | 13.83% | 2.98% | 12.89% | 3.12% | |
66 Neutral | $19.76B | 24.87 | 35.40% | 1.02% | 12.54% | 19.59% | |
66 Neutral | $93.83B | 11.75 | 33.83% | 6.55% | -1.25% | -2.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $25.12B | 50.75 | 18.26% | ― | -0.30% | -11.02% |